BioCryst Pharmaceuticals, Inc. · 16 hours ago
Sr. Manager, Quality Systems & Continuous Improvement
United States
Full-time
Remote
Senior Level
7+ years expBioCryst Pharmaceuticals, Inc. is committed to improving the lives of individuals with rare diseases through innovative medicine. The Senior Manager, Quality Systems and Continuous Improvement will drive quality initiatives within the Quality Management System while ensuring compliance with medical device regulations and leading internal audit programs.
BiotechnologyClinical TrialsTherapeutics
Responsibilities
Leads the identification and execution of quality and process improvements of Quality GxP process, driving continuous improvement initiatives using risk-based methodologies to enhance efficiency and compliance, in close collaboration with QA leadership and cross-functional teams
Lead the implementation and maintenance of combination products and medical device regulatory requirements (ISO 13485, 21 CFR 820, EU MDR) within BioCryst’s existing Quality Management System (QMS)
Translate ISO 13485, 21 CFR 820, and EU MDR requirements into practical QMS processes by developing and updating SOPs and work instructions to meet device-specific compliance needs
Manages and leads the Internal Audit Program across all GxPs ensuring a robust, risk-based framework aligned with global regulatory expectations. Partners with QA leadership to design, execute, and monitor the audit schedule, ensuring timely completion and proactive compliance
Responsible for the scheduling of the QMR, Quality Council and Quality council meetings, ensuring attendee lists are maintained, meetings are documented and slide decks are prepared and shared in advance where appropriate
Responsible for coordinating Quality Management Review (QMR), Quality Council, and related meetings, ensuring attendee lists are current, meetings are properly documented with minutes, and presentation materials are prepared and distributed in advance as appropriate
Designated back up for QA oversight of GxP Computer Systems Validation ensuring GxP IT systems are validated and maintained in accordance with regulatory requirements
QMS & Training support responsibilities include:
Act as the system administrator for the DMS and carry out processes utilized for the creation, editing, review and approval of controlled documentation (e.g., SOPs, Policies) and other documentation that utilizes the functions/features of the DMS to manage and hold documentation
Develop and maintain training documentation, including system vendor video training, slide decks and SOPs and work instructions specific to the DMS and QMS
Assign all required training to BioCryst users that need access to the DMS and QMS and ensure all training has been completed prior to granting system access
In collaboration with IT team members, and as Quality systems administrator, support all DMS, QMS, and LMS upgrades, including updates made at regular intervals, by reviewing for impact and completing testing/validation accordingly, where required
Set up new employees in the LMS and manage the curricula for all BioCryst employees based on input and feedback from the individual managers and their reviews per the BioCryst SOPs and policies
In collaboration with system vendors, work to resolve issues with system process flows that impact the documented processes
Collect and report metrics for the DMS, QMS and LMS as they relate to support and administration activities (e.g., late training, overdue actions, training assignments, etc.) to all levels of management and in the Quality Council and Quality Management Review Meeting
Provide support and contribute to other Quality Assurance activities as assigned
Qualification
Required
Bachelor's degree in Business Administration (or similar field), preferably with a technical concentration (IT, Business Systems, etc.) with a minimum of seven (7) years' experience in QA Management Systems (or similar) within a pharmaceutical or biotech environment or an equivalent of education and experience
Five (5) years (within the total experience required) should be in administration of quality systems such as document and/or learning management
Extensive knowledge of ISO 13485, 21 CFR 820, EU MDR with ability to design and implement QMS enhancements in alignment with these requirements
Knowledge of US, EU, ICH Regulations, guidelines and requirements
Proven track record of leading CI projects within QA/QMS processes
Thorough knowledge of administration of electronic Quality Systems and legacy paper systems for Quality processes supporting GxP activities
Strong understanding and intermediate to advanced software skills (e.g., Microsoft Excel, PowerPoint, Microsoft Project)
Excellent organizational skills and the ability to work on multiple projects with competitive timelines
Strong attention to detail and respect for the need of accurate information
Excellent communication and presentation skills
Ability to maintain high ethical standards
Proficient in working with people and information, making decisions, problem solving, making a difference, and working in a leadership role
Demonstrated ability to work effectively in cross-functional team environment and independently in a remote work setting, as necessary
Excellent problem-solving and decision-making skills
Strong knowledge of MS Office, including Word, Excel, PowerPoint and Outlook
Strong written and verbal communication skills
Company
BioCryst Pharmaceuticals, Inc.
BioCryst Pharmaceuticals is a global biotechnology company with a deep commitment to improving the lives of people living with hereditary angioedema (HAE) and other rare diseases.
501-1000 employees
H1B Sponsorship
BioCryst Pharmaceuticals, Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2021 (1)
Funding
Current Stage
Public CompanyTotal Funding
$1.76BKey Investors
MidCap FinancialNational Institute of Allergy and Infectious Diseases
2023-04-17Post Ipo Debt· $450M
2021-11-22Post Ipo Equity· $350M
2020-12-07Post Ipo Debt· $325M
Leadership Team
Charlie Gayer
President and Chief Commercial Officer
Nancy Hutson
Chair
Recent News
2026-01-22
Company data provided by crunchbase